on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Mural Oncology PLC
The Vanguard Group, Inc. has filed a Form 8.3 disclosure revealing its stake in Mural Oncology PLC. This disclosure, required under the Irish Takeover Panel Act, outlines Vanguard's interests in relevant securities. As of October 6, 2025, Vanguard owned 288,779 ordinary shares in Mural Oncology, representing 1.67% of the company's shares.
In addition, Vanguard reported minor trading activity, purchasing 304 shares and selling 64 shares at a price of 2.08 USD per share. No cash-settled or stock-settled derivatives transactions were reported, and no indemnity or other dealing arrangements were noted.
Vanguard has confirmed that there are no agreements or understandings related to options or derivatives concerning voting rights or future securities acquisitions. The disclosure emphasizes compliance with takeover rules amid ongoing market activities.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news